Cargando…
Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541432/ https://www.ncbi.nlm.nih.gov/pubmed/35770675 http://dx.doi.org/10.1111/dth.15679 |
_version_ | 1784803923136086016 |
---|---|
author | Megna, Matteo Villani, Alessia Potestio, Luca Camela, Elisa Fabbrocini, Gabriella Ocampo‐Garza, Sonia Sofia |
author_facet | Megna, Matteo Villani, Alessia Potestio, Luca Camela, Elisa Fabbrocini, Gabriella Ocampo‐Garza, Sonia Sofia |
author_sort | Megna, Matteo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9541432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95414322022-10-14 Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation Megna, Matteo Villani, Alessia Potestio, Luca Camela, Elisa Fabbrocini, Gabriella Ocampo‐Garza, Sonia Sofia Dermatol Ther Letters John Wiley & Sons, Inc. 2022-07-09 2022-09 /pmc/articles/PMC9541432/ /pubmed/35770675 http://dx.doi.org/10.1111/dth.15679 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Letters Megna, Matteo Villani, Alessia Potestio, Luca Camela, Elisa Fabbrocini, Gabriella Ocampo‐Garza, Sonia Sofia Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title | Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title_full | Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title_fullStr | Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title_full_unstemmed | Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title_short | Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation |
title_sort | adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation |
topic | Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541432/ https://www.ncbi.nlm.nih.gov/pubmed/35770675 http://dx.doi.org/10.1111/dth.15679 |
work_keys_str_mv | AT megnamatteo adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation AT villanialessia adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation AT potestioluca adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation AT camelaelisa adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation AT fabbrocinigabriella adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation AT ocampogarzasoniasofia adalimumabbiosimilarinapediatricpatientclinicalandinvivoreflectanceconfocalmicroscopyevaluation |